View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/FDA | RIN: 0910-AI43 | Publication ID: Fall 2021 |
Title: Labeling Requirements for Approved and Conditionally Approved New Animal Drugs | |
Abstract:
FDA is proposing to update existing requirements and establish new requirements for the format and content of labeling for prescription new animal drugs, new animal drugs for use in animal feed, and over-the-counter new animal drugs. The objective of the proposed rule is to protect the health of animals by providing pet owners and animal health professionals information in a more complete and uniform format on the labeling of approved and conditionally approved new animal drugs. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 21 CFR 201 21 CFR 500 21 CFR 501 21 CFR 510 21 CFR 514 ... (To search for a specific CFR, visit the Code of Federal Regulations.) | |
Legal Authority: 21 U.S.C. 321 21 U.S.C. 331 21 U.S.C. 351 21 U.S.C. 352 21 U.S.C. 360b 21 U.S.C. 360ccc 21 U.S.C. 371 21 U.S.C. 353 |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Undetermined |
Small Entities Affected: Businesses | Federalism: Undetermined |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Suzanne Sechen Supervisory Animal Scientist Department of Health and Human Services Food and Drug Administration Center for Veterinary Medicine, 7500 Standish Place, MPN-2, HFV-137, Rockville, MD 20855 Phone:240 402-0814 Email: suzanne.sechen@fda.hhs.gov |